Intersection of mTOR and STAT signaling in immunity D Saleiro, LC Platanias Trends in immunology 36 (1), 21-29, 2015 | 143 | 2015 |
Estrogen receptor‐β protects against colitis‐associated neoplasia in mice D Saleiro, G Murillo, RV Benya, M Bissonnette, J Hart, RG Mehta International journal of cancer 131 (11), 2553-2561, 2012 | 94 | 2012 |
Central role of ULK1 in type I interferon signaling D Saleiro, S Mehrotra, B Kroczynska, EM Beauchamp, P Lisowski, ... Cell reports 11 (4), 605-617, 2015 | 80 | 2015 |
Targeting novel signaling pathways for resistant acute myeloid leukemia KM Sakamoto, S Grant, D Saleiro, JD Crispino, N Hijiya, F Giles, ... Molecular genetics and metabolism 114 (3), 397-402, 2015 | 71 | 2015 |
Type I and II interferons in the anti-tumor immune response SE Fenton, D Saleiro, LC Platanias Cancers 13 (5), 1037, 2021 | 65 | 2021 |
Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma AD Arslan, A Sassano, D Saleiro, P Lisowski, EM Kosciuczuk, M Fischietti, ... Oncogene 36 (43), 6006-6019, 2017 | 61 | 2017 |
Differential protective effects of red wine polyphenol extracts (RWEs) on colon carcinogenesis F Mazué, D Delmas, G Murillo, D Saleiro, E Limagne, N Latruffe Food & function 5 (4), 663-670, 2014 | 55 | 2014 |
Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints D Saleiro, LC Platanias Seminars in immunology 43, 101299, 2019 | 47 | 2019 |
Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo EM Kosciuczuk, D Saleiro, B Kroczynska, EM Beauchamp, F Eckerdt, ... Blood, The Journal of the American Society of Hematology 128 (3), 410-414, 2016 | 47 | 2016 |
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia EM Kosciuczuk, D Saleiro, LC Platanias Cytokine 89, 116-121, 2017 | 34 | 2017 |
Interferon γ (IFNγ) signaling via mechanistic target of rapamycin complex 2 (mTORC2) and regulatory effects in the generation of type II interferon biological responses B Kroczynska, RL Rafidi, B Majchrzak-Kita, EM Kosciuczuk, GT Blyth, ... Journal of Biological Chemistry 291 (5), 2389-2396, 2016 | 33 | 2016 |
Sirtuin 2–mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses EM Kosciuczuk, S Mehrotra, D Saleiro, B Kroczynska, B Majchrzak-Kita, ... Journal of Biological Chemistry 294 (3), 827-837, 2019 | 26 | 2019 |
A palette of cytokines to measure anti-tumor efficacy of T cell-based therapeutics P Ramesh, R Shivde, D Jaishankar, D Saleiro, IC Le Poole Cancers 13 (4), 821, 2021 | 25 | 2021 |
Slfn2 Regulates Type I Interferon Responses by Modulating the NF-κB Pathway M Fischietti, AD Arslan, A Sassano, D Saleiro, B Majchrzak-Kita, K Ebine, ... Molecular and cellular biology 38 (16), e00053-18, 2018 | 23 | 2018 |
IFN-γ–inducible antiviral responses require ULK1-mediated activation of MLK3 and ERK5 D Saleiro, GT Blyth, EM Kosciuczuk, PA Ozark, B Majchrzak-Kita, ... Science signaling 11 (557), eaap9921, 2018 | 22 | 2018 |
Beyond autophagy: new roles for ULK1 in immune signaling and interferon responses D Saleiro, EM Kosciuczuk, LC Platanias Cytokine & growth factor reviews 29, 17-22, 2016 | 20 | 2016 |
Enhanced Induction of Mucin-Depleted Foci in Estrogen Receptor β Knockout Mice D Saleiro, G Murillo, DB Lubahn, L Kopelovich, KS Korach, RG Mehta Cancer Prevention Research 3 (9), 1198-1204, 2010 | 18 | 2010 |
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms D Saleiro, JQ Wen, EM Kosciuczuk, F Eckerdt, EM Beauchamp, CV Oku, ... Nature communications 13 (1), 1750, 2022 | 17 | 2022 |
Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinase M Colamonici, G Blyth, D Saleiro, A Szilard, M Bliss-Moreau, FJ Giles, ... Oncotarget 6 (10), 8062, 2015 | 15 | 2015 |
Inhibitory effects of SEL201 in acute myeloid leukemia EM Kosciuczuk, AK Kar, GT Blyth, M Fischietti, S Abedin, AA Mina, ... Oncotarget 10 (67), 7112, 2019 | 14 | 2019 |